Amicus Therapeutics
FOLD
#3390
Rank
NZ$5.62 B
Marketcap
$18.95
Share price
-1.22%
Change (1 day)
0.50%
Change (1 year)

Earnings for Amicus Therapeutics (FOLD)

Earnings in 2024 (TTM): -NZ$0.17 Billion

According to Amicus Therapeutics 's latest financial reports the company's current earnings are NZ$0.45 Billion. In 2023 the company made an earning of -NZ$0.26 Billion, an increase over its 2022 earnings that were of -NZ$0.41 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Amicus Therapeutics from 2007 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -NZ$0.17 Billion-34.63%
2023 -NZ$0.26 Billion-37.98%
2022 -NZ$0.41 Billion0.2%
2021 -NZ$0.41 Billion-11.92%
2020 -NZ$0.46 Billion-22.94%
2019 -NZ$0.6 Billion1.95%
2018 -NZ$0.59 Billion-22.27%
2017 -NZ$0.76 Billion120.39%
2016 -NZ$0.35 Billion54.24%
2015 -NZ$0.23 Billion88.63%
2014 -NZ$0.12 Billion10.92%
2013 -NZ$0.11 Billion21.36%
2012 -NZ$87.05 Million8.3%
2011 -NZ$80.37 Million-14.33%
2010 -NZ$93.81 Million753.76%
2009 -NZ$10.99 Million-83.31%
2008 -NZ$65.84 Million-4.4%
2007 -NZ$68.87 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
NZ$2.19 B-1,416.01%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.65 B-492.08%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$68.09 Million-59.24%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$6.97 B-4,277.55%๐Ÿ‡ฌ๐Ÿ‡ง UK
-NZ$0.34 Billion 102.43%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$28.19 B-16,980.21%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark